Entry Rationale
The closing price of 53.85 on August 24, 2026, is positioned just below the resistance level of 55, leading us to consider a buy based on the positive earnings guidance and revenue growth targets supporting further increases.
Lemonade reiterates Q4 2026 positive adjusted EBITDA while raising 2026 revenue guidance and targeting 33% IFP growth
Lemonade has reaffirmed that its adjusted EBITDA for the fourth quarter of 2026 will be positive and has raised its revenue guidance for 2026, setting a target growth rate of 33% for IFP (Insurance Premium Revenue).
The closing price of 53.85 on August 24, 2026, is positioned just below the resistance level of 55, leading us to consider a buy based on the positive earnings guidance and revenue growth targets supporting further increases.
If the stock price breaks through the resistance level of 55, the target for an increase will be set at 58 for profit-taking. Conversely, if the stock price reaches the support level of 45 and falls to 42, a stop-loss will be executed.
The actual return of 10.2% exceeded the forecasted return of 8.5%. Positive news and buying near the resistance level accurately contributed to the continuation of upward momentum, and the price did not fall to the stop-loss level, indicating effective risk management. However, if the stop-loss criteria had been set more tightly, there would have been room to prepare for downside risk.
In the next trade, we will confirm a clearer entry signal at the point of breaking through the resistance level, and immediately after entering, we will set the initial stop-loss at a level of 52, which is 2-3% below the resistance level, to minimize downside risk. Additionally, we will continuously monitor regular reports such as SEC filings, but we plan to place greater emphasis on key positive factors like earnings guidance to optimize the timing of our entry.